Bottom line
BHCFX vs ETHSX: the short answer
BHCFX (Baron Health Care Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both mutual funds.
BHCFX is cheaper at 1.1% vs 1.18% — a difference of $8.00 a year per $10,000 invested.
Over five years, ETHSX returned +5.3% a year vs +2.5% for BHCFX (reporting dates differ).
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
BHCFX vs ETHSX side by side
| BHCFX | ETHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Baron Select | Morgan Stanley |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.1% | 1.18% |
| Annual cost per $10k | $110 | $118 |
| 10-yr cost on $10k (prospectus) | $1,340 | $1,911 |
| Max front load | — | 5.25% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +10.0% | −1.9% |
| 5-yr return (annualized) | +2.5% | +5.3% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +24.6% | +14.2% |
| Worst quarter | −10.0% | −12.1% |
| Net assets (fund) | $114.1M | $757.9M |
| Number of holdings | 43 | 42 |
| Portfolio turnover | 74% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BHCFX | ETHSX | Difference |
|---|---|---|---|
| 2024 | +1.3% | +3.5% | −2.3% |
| 2023 | +6.2% | +5.7% | +0.5% |
| 2022 | −17.1% | −9.4% | −7.7% |
| 2021 | +15.5% | +22.1% | −6.6% |
| 2020 | +47.4% | +13.0% | +34.4% |
| 2019 | +35.2% | +26.0% | +9.2% |
Source: Fund prospectus bar charts
Holdings overlap
11 of BHCFX's top 25 holdings also appear in ETHSX's top 25.
| Holding | BHCFX | ETHSX |
|---|---|---|
| Eli Lilly & Co | 13.66% | 12.47% |
| Mettler-Toledo International Inc | 5.60% | 1.36% |
| Johnson & Johnson | 5.56% | 6.45% |
| Argenx SE | 4.23% | 1.61% |
| Thermo Fisher Scientific Inc | 3.91% | 2.79% |
| UnitedHealth Group Inc | 3.28% | 5.49% |
| Vertex Pharmaceuticals Inc | 2.61% | 3.38% |
| AstraZeneca PLC | 2.49% | 6.24% |
| Merck & Co Inc | 2.48% | 5.08% |
| Gilead Sciences Inc | 1.99% | 3.34% |
| Intuitive Surgical Inc | 1.74% | 2.72% |
Source: SEC Form N-PORT
BHCFX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
FAQ
What is the difference between BHCFX and ETHSX?
Which is cheaper, BHCFX or ETHSX?
Should I own both BHCFX and ETHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.